Development of Novel Genomic Blood Biomarkers for Neurodegenerative Diseases

E-ISSN： 1996-3181|9|6|669-678

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.9, Iss.6, 2010-12, pp. : 669-678

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Unbiased Search of Biomarkers in Neurodegenerative Diseases

Current Pharmaceutical Biotechnology, Vol. 17, Iss. 5, 2016-04 ,pp. : 471-479

Bentham Science Publishers

Access to resources Recommend Favorite

Systemic Redox Biomarkers in Neurodegenerative Diseases

Current Drug Metabolism, Vol. 16, Iss. 1, 2015-01 ,pp. : 46-70

Bentham Science Publishers

Access to resources Recommend Favorite

Neuronal High-Affinity Sodium-Dependent Glutamate Transporters (EAATs): Targets for the Development of Novel Therapeutics Against Neurodegenerative Diseases

Current Pharmaceutical Design, Vol. 9, Iss. 8, 2003-03 ,pp. : 599-625

Bentham Science Publishers

Access to resources Recommend Favorite

Issues for Clinical Drug Development in Neurodegenerative Diseases

By Dib Michel

Drugs, Vol. 65, Iss. 17, 2005-01 ,pp. : 2463-2479

Adis International

Access to resources Recommend Favorite

Editorial (Thematic Issue: Peptides as a Novel Therapeutic Approach for Neurodegenerative Diseases)

Current Medicinal Chemistry, Vol. 21, Iss. 23, 2014-08 ,pp. : 2573-2574

Bentham Science Publishers

Access to resources Recommend Favorite